Volociximab (Anti-Integrin a5b1 (ITGA5 & ITGB1)) | Integrin antibody

Volociximab (Anti-Integrin a5b1 (ITGA5 & ITGB1)) is a monoclonal antibody targeting Integrin a5b1 (ITGA5 & ITGB1). It can be used in treatment of solid tumors, renal cell carcinoma, melanoma, pancreatic cancer, lung cancer, and ovarian cancer. MW :145.52 KD.

Purity & Quality Control

Batch: Purity: 99% Protein concentration: 9.96mg/ml Endotoxin Level: ＜1EU/mg

99

Choose Selective Integrin Inhibitors

Biological Activity

Description	Volociximab (Anti-Integrin a5b1 (ITGA5 & ITGB1)) is a monoclonal antibody targeting Integrin a5b1 (ITGA5 & ITGB1). It can be used in treatment of solid tumors, renal cell carcinoma, melanoma, pancreatic cancer, lung cancer, and ovarian cancer. MW :145.52 KD.

References
[1] Ng CM, et al. Cancer Chemother Pharmacol. 2010 Jan;65(2):207-17

References

[1] Ng CM, et al. Cancer Chemother Pharmacol. 2010 Jan;65(2):207-17

Product Details

CAS No.	558480-40-3
Isotype	Human IgG4SP
Source	CHO
Formulation	100mMPro-Ac,20mMArg-Ac，pH5.0
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field